Antengene Corporation Limited Stock price
Equities
6996
KYG039571008
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 HKD | -0.99% | -10.71% | -50.00% |
Sales 2023 | 67.3M 9.32M 72.97M | Sales 2024 * | 140M 19.35M 151M | Capitalization | 623M 86.34M 676M |
---|---|---|---|---|---|
Net income 2023 | -581M -80.49M -630M | Net income 2024 * | -475M -65.81M -515M | EV / Sales 2023 | 18.2 x |
Net Debt 2023 * | 57.96M 8.03M 62.83M | Net Debt 2024 * | 201M 27.85M 218M | EV / Sales 2024 * | 5.9 x |
P/E ratio 2023 |
-1.93
x | P/E ratio 2024 * |
-1.26
x | Employees | 201 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 53.36% |
1 day | -0.99% | ||
1 week | -10.71% | ||
Current month | -19.35% | ||
1 month | -20.00% | ||
3 months | -46.81% | ||
6 months | -18.70% | ||
Current year | -50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Jian Ming Mei
CEO | Chief Executive Officer | 58 | 18-08-27 |
Director of Finance/CFO | 42 | - | |
Xiao-Jing Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rafael Fonseca
BRD | Director/Board Member | 57 | 23-04-13 |
Jian Ming Mei
CEO | Chief Executive Officer | 58 | 18-08-27 |
Yiteng Liu
COO | Chief Operating Officer | 40 | 18-11-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.40% | 4 M€ | -27.92% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1 | -0.99% | 362,500 |
24-03-27 | 1.01 | 0.00% | 97,500 |
24-03-26 | 1.01 | -0.98% | 115,000 |
24-03-25 | 1.02 | -5.56% | 578,500 |
24-03-22 | 1.08 | -3.57% | 145,500 |
Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.00% | 86.24M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |